The success of GLP-1 receptor agonists/analogues has transformed metabolic disease treatment while demonstrating the potential of engineered peptides to deliver long-acting, highly targeted therapies.

Rep. David Rowe, Chairman of the Pennsylvania House Republican Policy Committee, far right, conducted a hearing on Tuesday at the Friedman JCC in Kingston titled ‘Small Communities, Big Costs: ...

Reach customers where they live, work, and scroll. With 665,386 unique visits in the past 28 days alone, timesleader.com stands as one of the most highly trafficked websites in Northeastern ...

A rare and distinguished opportunity is coming to one of Philadelphia’s most prestigious neighborhoods… Becker, a multi-practice commercial law firm with attorneys, lobbyists, and other professionals, ...